BIO Stockholders Equity

Bio-Rad Laboratories, Inc. Class A Common Stock · Stockholders Equity

BIO logo

BIO Stockholders Equity

Latest reported$7.45B
BIO FY Shareholders Equity ($29.90M → $7.45B)
High-resolution chart · PNG

BIO stockholders equity history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bio-Rad Laboratories, Inc. Class A Common Stock Stockholders Equity — Annual fiscal periods (USD)
Period endingStockholders Equity (USD)
7,453,600,000
6,569,300,000
8,741,200,000
9,615,252,000
13,685,236,000
9,879,940,000
5,755,057,000
4,020,331,000
2,930,250,000
2,579,160,000
2,490,503,000
2,185,155,000
2,186,722,000
2,015,005,000
1,743,937,000
1,536,696,000
1,259,726,000
1,041,139,000
971,690,000
819,538,000
657,974,000
596,888,000
495,807,000
383,087,000
283,877,000
244,618,000
220,100,000
214,300,000
196,700,000
183,500,000
157,100,000
129,800,000
110,300,000
107,100,000
90,800,000
81,100,000
68,900,000
59,500,000
50,100,000
43,300,000
29,900,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.